Showing results (361-370 of 809) with videos related to
Sort By:
Pageof 81
Clinical Endocrinology|September 30, 2010
Gender differences in the association of C-reactive protein with coronary artery calcium in type-2 diabetesAtif N Qasim, Venkata Budharaju, Nehal N Mehta, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|August 8, 2009
Macrophage reverse cholesterol transport in mice expressing ApoA-I MilanoEric T Alexander, Ginny L Weibel, Michelle R Joshi, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 26, 2011
Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) StudyMatthew J Budoff, Daniel J Rader, Muredach P Reilly, et al.Journal of the American Academy of Dermatology|October 25, 2011
Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasisAlexa B Kimball, Philippe Szapary, Ulrich Mrowietz, et al.Proceedings of the National Academy of Sciences of the United States of America|February 28, 2003
Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipaseOuliana Ziouzenkova, Stephane Perrey, Liana Asatryan, et al.Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 4, 2008
Diabetes reduces bone marrow and circulating porcine endothelial progenitor cells, an effect ameliorated by atorvastatin and independent of cholesterolEmile R Mohler, Yuquan Shi, Jonni Moore, et al.Nature Communications|June 24, 2025
Apolipoprotein M attenuates age-related macular degeneration phenotypes via sphingosine-1-phosphate signaling and lysosomal lipid catabolismTae Jun Lee, Andrea Santeford, Kristen M Pitts, et al.The Journal of Clinical Endocrinology and Metabolism|June 6, 2019
Efficacy and Safety of Alirocumab 300 mg Every 4 Weeks in Individuals With Type 2 Diabetes on Maximally Tolerated StatinDirk Müller-Wieland, Daniel J Rader, Patrick M Moriarty, et al.Journal of the American College of Cardiology|November 14, 2015
Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With EvacetrapibStephen J Nicholls, Giacomo Ruotolo, H Bryan Brewer, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|December 19, 2009
Pathways by which reconstituted high-density lipoprotein mobilizes free cholesterol from whole body and from macrophagesMarina Cuchel, Sissel Lund-Katz, Margarita de la Llera-Moya, et al.Pageof 81